Inotiv, INC 10-Q quarterly reports

Inotiv, Inc. (NOTV) filed its Form 10-Q for the quarter ended March 31, 2026, revealing a significant increase in net loss and highlighting substantial going concern risks due to debt obligations and covenant compliance.

Inotiv, Inc. reports increased net loss and negative cash flow, raising substantial doubt about its ability to continue as a going concern, despite growth in its DSA segment.

Inotiv, Inc. reported a significant reduction in net loss and increased revenue for the quarter ended June 30, 2025, while also announcing the favorable conclusion of an SEC investigation.

Inotiv's Q2 2025 results show a mixed performance with a slight revenue increase but a significant reduction in net loss, driven by strategic initiatives and cost management.

Inotiv's Q1 2025 results reveal a decrease in revenue and a widened net loss, driven by lower RMS segment performance, as the company focuses on strategic objectives including liquidity improvement and NHP revenue stabilization.

Inotiv Inc. reported a net loss for Q3 2024, impacted by decreased revenue in its Research Models and Services segment and ongoing challenges in the non-human primate market, while also navigating debt covenant compliance.

Inotiv, Inc. has filed an amendment to its quarterly report to correct financial figures and address ongoing concerns about its ability to continue as a going concern.

Inotiv Inc. reports a net loss for Q2 2024, impacted by decreased revenue in its Research Models and Services segment and a charge related to an agreement in principle with the Department of Justice.

Inotiv, Inc. saw revenue growth in the first quarter of fiscal year 2024, driven by both its Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments, while also reporting a reduced net loss compared to the same period last year.